Laura Pujols
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.
Journal: Clinical and translational allergy
Published: October 02, 2020
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.
Journal: Clinical and translational allergy
Published: November 30, 2019
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: September 20, 2018
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis.
Journal: Rhinology
Published: May 15, 2017
Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.
Journal: Current allergy and asthma reports
Published: July 03, 2015
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease.
Journal: The Journal of allergy and clinical immunology
Published: June 16, 2015
Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.
Journal: The Laryngoscope
Published: November 04, 2014
Fluticasone furoate inhibits cytokine secretion from nasal epithelial cells and reduces eosinophil survival in an in vitro model of eosinophilic inflammation.
Journal: International archives of allergy and immunology
Published: July 10, 2013
Differential expression of remodeling markers by tissue structure in nasal polyposis.
Journal: American journal of rhinology & allergy
Published: May 29, 2013
Last Updated: 09/26/2026